How Novartis And Ionis' High-Profile Failure Reverberated Through Biopharma

Novartis and Ionis' high-profile Lp(a) flop on Friday reverberated through biotech stocks on Tuesday, leading to a widespread drop. The post How Novartis And Ionis' High-Profile Failure Reverberated Through Biopharma appeared first on Investor's Business Daily.